GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Cirrhosis Liver/Prior Ascites or Encephalopathy Signals High Risk After Variceal Bleeding: CGH | August 2026
4

Prior Ascites or Encephalopathy Signals High Risk After Variceal Bleeding: CGH | August 2026

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated September 1, 2026

Introduction:

After variceal haemorrhage, secondary prophylaxis with nonselective beta-blockers (NSBBs) plus endoscopic variceal ligation (EVL) is standard. However, prognosis may differ substantially according to the patient’s previous pattern of hepatic decompensation. This study examined whether prior ascites or hepatic encephalopathy (HE) identifies patients at particularly high risk.

Why was this study needed?

Variceal bleeding occurs across a wide spectrum of decompensated cirrhosis.

Previous decompensation is often considered as a single category.

Ascites, HE, and previous bleeding may carry different prognostic implications.

Better risk stratification could identify patients needing earlier transplant or TIPS assessment.

Key Findings:

Patients with previous ascites or HE had substantially worse survival despite NSBB + EVL secondary prophylaxis.

Two-year mortality was 25.1% with previous decompensation vs 13.5% without.

Previous ascites was associated with a 79% higher adjusted mortality risk.

Previous HE was associated with a 71% higher adjusted mortality risk.

Importantly, previous variceal bleeding alone did not carry the same excess mortality.

Prior ascites may therefore identify patients who warrant earlier and more intensive liver-transplant evaluation.

Broader use of TIPS in these high-risk patients is an important research question, but requires randomised validation.

Previous HE creates a particular dilemma because TIPS itself may increase the risk of recurrent encephalopathy.

Bottom Line:

Not all previous decompensation carries the same prognosis after variceal bleeding. Prior ascites or HE identifies a particularly high-risk group who may warrant earlier transplant assessment and individualised consideration of TIPS.

Related Q&A

05

PEth Improves Classification of MASLD, MetALD and Alcohol-Associated Liver Disease: Lancet Gastroenterology & Hepatology | September 2026

Introduction: Distinguishing MASLD, MetALD and alcohol-associated liver disease (ALD) depends heavily on self-reported alcohol intake, which is vulnerable to underreporting. This prospective study evaluated phosphatidylethanol (PEth) as an...

06

RPR Predicts Short-Term Acute Decompensation in Alcohol-Related Cirrhosis: Digestive and Liver Disease | 2026

Introduction: Patients with alcohol-related cirrhosis and non-acute decompensation (NAD) may appear sufficiently stable for outpatient management but remain at substantial risk of rapidly progressing to hospitalisation-requiring acute decompensation...

07

ACLF Needs One Language: Journal of Hepatology | August 2026

Introduction: Acute-on-chronic liver failure (ACLF) is a high-mortality syndrome characterised by acute deterioration of chronic liver disease with organ dysfunction or failure. Yet, unlike conditions such as sepsis...

08

Breath-Based Sensor (LivSens) Shows Promise for Screening HE: JHE | August 2026

Hepatic encephalopathy (HE) is usually diagnosed through clinical assessment and psychometric testing, but these approaches can be time-consuming and require trained personnel. LivSens is a portable multisensor breath-analysis...

09

Breath-Based Diagnostics: Measuring the Liver’s Functional Reserve in Real Time: CGH | August 2026

Introduction: Current assessment of chronic liver disease relies largely on static biomarkers and structural measurements such as laboratory scores, elastography, imaging, and liver biopsy. However, fibrosis severity does...

10

Hyponatremia in Cirrhosis: Low Sodium Reflects Excess Water, Not Sodium Deficiency: AASLD Clinical Pearls | August 2026

Introduction: Hyponatremia is common in advanced cirrhosis, particularly in patients with ascites, and reflects impaired free-water excretion due to effective arterial underfilling rather than true sodium depletion in...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer